Aortic Counterpulsation Therapy in Patients with Advanced Heart Failure: Analysis of the TBRIDGE Registry

Abstract Background: The use of aortic counterpulsation therapy in advanced heart failure is controversial. Objectives: To evaluate the hemodynamic and metabolic effects of intra-aortic balloon pump (IABP) and its impact on 30-day mortality in patients with heart failure. Methods: Historical prospective, unicentric study to evaluate all patients treated with IABP betwen August/2008 and July/2013, included in an institutional registry named TBRIDGE (The Brazilian Registry of Intra-aortic balloon pump in Decompensated heart failure - Global Evaluation). We analyzed changes in oxygen central venous saturation (ScvO2), arterial lactate, and use of vasoactive drugs at 48 hours after IABP insertion. The 30-day mortality was estimated by the Kaplan-Meier method and diferences in subgroups were evaluated by the Log-rank test. Results: A total of 223 patients (mean age 49 ± 14 years) were included. Mean left ventricle ejection fraction was 24 ± 10%, and 30% of patients had Chagas disease. Compared with pre-IABP insertion, we observed an increase in ScvO2 (50.5% vs. 65.5%, p < 0.001) and use of nitroprusside (33.6% vs. 47.5%, p < 0.001), and a decrease in lactate levels (31.4 vs. 16.7 mg/dL, p < 0.001) and use of vasopressors (36.3% vs. 25.6%, p = 0.003) after IABP insertion. Thirty-day survival was 69%, with lower mortality in Chagas disease patients compared without the disease (p = 0.008). Conclusion: After 48 hours of use, IABP promoted changes in the use of vasoactive drugs, improved tissue perfusion. Chagas etiology was associated with lower 30-day mortality. Aortic counterpulsation therapy is an effective method of circulatory support for patients waiting for heart transplantation.

Saved in:
Bibliographic Details
Main Authors: Bezerra,Cristiano Guedes, Adam,Eduardo Leal, Baptista,Mariana Lins, Ciambelli,Giuliano Serafino, Kopel,Liliane, Bernoche,Claudia, Lopes,Leonardo Nicolau Geisler Daud, Macatrão-Costa,Milena Frota, Falcão,Breno de Alencar Araripe, Lage,Silvia Gelas
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Cardiologia - SBC 2016
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2016000100026
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0066-782X2016000100026
record_format ojs
spelling oai:scielo:S0066-782X20160001000262016-01-22Aortic Counterpulsation Therapy in Patients with Advanced Heart Failure: Analysis of the TBRIDGE RegistryBezerra,Cristiano GuedesAdam,Eduardo LealBaptista,Mariana LinsCiambelli,Giuliano SerafinoKopel,LilianeBernoche,ClaudiaLopes,Leonardo Nicolau Geisler DaudMacatrão-Costa,Milena FrotaFalcão,Breno de Alencar AraripeLage,Silvia Gelas Shock, Cardiogenic / mortality Heart Failure Chagas Cardiomyopathy Intra-Aortic Balloon Pump Heart Transplanation Counterpulsation Abstract Background: The use of aortic counterpulsation therapy in advanced heart failure is controversial. Objectives: To evaluate the hemodynamic and metabolic effects of intra-aortic balloon pump (IABP) and its impact on 30-day mortality in patients with heart failure. Methods: Historical prospective, unicentric study to evaluate all patients treated with IABP betwen August/2008 and July/2013, included in an institutional registry named TBRIDGE (The Brazilian Registry of Intra-aortic balloon pump in Decompensated heart failure - Global Evaluation). We analyzed changes in oxygen central venous saturation (ScvO2), arterial lactate, and use of vasoactive drugs at 48 hours after IABP insertion. The 30-day mortality was estimated by the Kaplan-Meier method and diferences in subgroups were evaluated by the Log-rank test. Results: A total of 223 patients (mean age 49 ± 14 years) were included. Mean left ventricle ejection fraction was 24 ± 10%, and 30% of patients had Chagas disease. Compared with pre-IABP insertion, we observed an increase in ScvO2 (50.5% vs. 65.5%, p < 0.001) and use of nitroprusside (33.6% vs. 47.5%, p < 0.001), and a decrease in lactate levels (31.4 vs. 16.7 mg/dL, p < 0.001) and use of vasopressors (36.3% vs. 25.6%, p = 0.003) after IABP insertion. Thirty-day survival was 69%, with lower mortality in Chagas disease patients compared without the disease (p = 0.008). Conclusion: After 48 hours of use, IABP promoted changes in the use of vasoactive drugs, improved tissue perfusion. Chagas etiology was associated with lower 30-day mortality. Aortic counterpulsation therapy is an effective method of circulatory support for patients waiting for heart transplantation.info:eu-repo/semantics/openAccessSociedade Brasileira de Cardiologia - SBCArquivos Brasileiros de Cardiologia v.106 n.1 20162016-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2016000100026en10.5935/abc.20150147
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Bezerra,Cristiano Guedes
Adam,Eduardo Leal
Baptista,Mariana Lins
Ciambelli,Giuliano Serafino
Kopel,Liliane
Bernoche,Claudia
Lopes,Leonardo Nicolau Geisler Daud
Macatrão-Costa,Milena Frota
Falcão,Breno de Alencar Araripe
Lage,Silvia Gelas
spellingShingle Bezerra,Cristiano Guedes
Adam,Eduardo Leal
Baptista,Mariana Lins
Ciambelli,Giuliano Serafino
Kopel,Liliane
Bernoche,Claudia
Lopes,Leonardo Nicolau Geisler Daud
Macatrão-Costa,Milena Frota
Falcão,Breno de Alencar Araripe
Lage,Silvia Gelas
Aortic Counterpulsation Therapy in Patients with Advanced Heart Failure: Analysis of the TBRIDGE Registry
author_facet Bezerra,Cristiano Guedes
Adam,Eduardo Leal
Baptista,Mariana Lins
Ciambelli,Giuliano Serafino
Kopel,Liliane
Bernoche,Claudia
Lopes,Leonardo Nicolau Geisler Daud
Macatrão-Costa,Milena Frota
Falcão,Breno de Alencar Araripe
Lage,Silvia Gelas
author_sort Bezerra,Cristiano Guedes
title Aortic Counterpulsation Therapy in Patients with Advanced Heart Failure: Analysis of the TBRIDGE Registry
title_short Aortic Counterpulsation Therapy in Patients with Advanced Heart Failure: Analysis of the TBRIDGE Registry
title_full Aortic Counterpulsation Therapy in Patients with Advanced Heart Failure: Analysis of the TBRIDGE Registry
title_fullStr Aortic Counterpulsation Therapy in Patients with Advanced Heart Failure: Analysis of the TBRIDGE Registry
title_full_unstemmed Aortic Counterpulsation Therapy in Patients with Advanced Heart Failure: Analysis of the TBRIDGE Registry
title_sort aortic counterpulsation therapy in patients with advanced heart failure: analysis of the tbridge registry
description Abstract Background: The use of aortic counterpulsation therapy in advanced heart failure is controversial. Objectives: To evaluate the hemodynamic and metabolic effects of intra-aortic balloon pump (IABP) and its impact on 30-day mortality in patients with heart failure. Methods: Historical prospective, unicentric study to evaluate all patients treated with IABP betwen August/2008 and July/2013, included in an institutional registry named TBRIDGE (The Brazilian Registry of Intra-aortic balloon pump in Decompensated heart failure - Global Evaluation). We analyzed changes in oxygen central venous saturation (ScvO2), arterial lactate, and use of vasoactive drugs at 48 hours after IABP insertion. The 30-day mortality was estimated by the Kaplan-Meier method and diferences in subgroups were evaluated by the Log-rank test. Results: A total of 223 patients (mean age 49 ± 14 years) were included. Mean left ventricle ejection fraction was 24 ± 10%, and 30% of patients had Chagas disease. Compared with pre-IABP insertion, we observed an increase in ScvO2 (50.5% vs. 65.5%, p < 0.001) and use of nitroprusside (33.6% vs. 47.5%, p < 0.001), and a decrease in lactate levels (31.4 vs. 16.7 mg/dL, p < 0.001) and use of vasopressors (36.3% vs. 25.6%, p = 0.003) after IABP insertion. Thirty-day survival was 69%, with lower mortality in Chagas disease patients compared without the disease (p = 0.008). Conclusion: After 48 hours of use, IABP promoted changes in the use of vasoactive drugs, improved tissue perfusion. Chagas etiology was associated with lower 30-day mortality. Aortic counterpulsation therapy is an effective method of circulatory support for patients waiting for heart transplantation.
publisher Sociedade Brasileira de Cardiologia - SBC
publishDate 2016
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2016000100026
work_keys_str_mv AT bezerracristianoguedes aorticcounterpulsationtherapyinpatientswithadvancedheartfailureanalysisofthetbridgeregistry
AT adameduardoleal aorticcounterpulsationtherapyinpatientswithadvancedheartfailureanalysisofthetbridgeregistry
AT baptistamarianalins aorticcounterpulsationtherapyinpatientswithadvancedheartfailureanalysisofthetbridgeregistry
AT ciambelligiulianoserafino aorticcounterpulsationtherapyinpatientswithadvancedheartfailureanalysisofthetbridgeregistry
AT kopelliliane aorticcounterpulsationtherapyinpatientswithadvancedheartfailureanalysisofthetbridgeregistry
AT bernocheclaudia aorticcounterpulsationtherapyinpatientswithadvancedheartfailureanalysisofthetbridgeregistry
AT lopesleonardonicolaugeislerdaud aorticcounterpulsationtherapyinpatientswithadvancedheartfailureanalysisofthetbridgeregistry
AT macatraocostamilenafrota aorticcounterpulsationtherapyinpatientswithadvancedheartfailureanalysisofthetbridgeregistry
AT falcaobrenodealencarararipe aorticcounterpulsationtherapyinpatientswithadvancedheartfailureanalysisofthetbridgeregistry
AT lagesilviagelas aorticcounterpulsationtherapyinpatientswithadvancedheartfailureanalysisofthetbridgeregistry
_version_ 1756381984838385664